Global Epigenomic Market Growth (Status and Outlook) 2018-2023

Report ID: 72ac8e5ee747 Category: Pages: 115 LPI(LP Information) 10/22/2018

$3,660$7,320

Clear

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
Over the next five years, LPI(LP Information) projects that Epigenomic will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Epigenomic market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of Epigenomic market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
Reagents
Kits
Enzymes
Services
Segmentation by application:
Oncology
Non Oncology

We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Roche Diagnostics
Thermo Fisher Scientific
Eisai
Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Epigenomic market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Epigenomic market by identifying its various subsegments.
Focuses on the key global Epigenomic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Epigenomic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Epigenomic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Report ID: 72ac8e5ee747 Category: Pages: 115 LPI(LP Information) 10/22/2018

Table of Contents

2018-2023 Global Epigenomic Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Epigenomic Market Size 2013-2023
2.1.2 Epigenomic Market Size CAGR by Region
2.2 Epigenomic Segment by Type
2.2.1 Reagents
2.2.2 Kits
2.2.3 Instruments
2.2.4 Enzymes
2.2.5 Services
2.3 Epigenomic Market Size by Type
2.3.1 Global Epigenomic Market Size Market Share by Type (2013-2018)
2.3.2 Global Epigenomic Market Size Growth Rate by Type (2013-2018)
2.4 Epigenomic Segment by Application
2.4.1 Oncology
2.4.2 Non Oncology
2.5 Epigenomic Market Size by Application
2.5.1 Global Epigenomic Market Size Market Share by Application (2013-2018)
2.5.2 Global Epigenomic Market Size Growth Rate by Application (2013-2018)

3 Global Epigenomic by Players
3.1 Global Epigenomic Market Size Market Share by Players
3.1.1 Global Epigenomic Market Size by Players (2016-2018)
3.1.2 Global Epigenomic Market Size Market Share by Players (2016-2018)
3.2 Global Epigenomic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Epigenomic by Regions
4.1 Epigenomic Market Size by Regions
4.2 Americas Epigenomic Market Size Growth
4.3 APAC Epigenomic Market Size Growth
4.4 Europe Epigenomic Market Size Growth
4.5 Middle East & Africa Epigenomic Market Size Growth

5 Americas
5.1 Americas Epigenomic Market Size by Countries
5.2 Americas Epigenomic Market Size by Type
5.3 Americas Epigenomic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Epigenomic Market Size by Countries
6.2 APAC Epigenomic Market Size by Type
6.3 APAC Epigenomic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Epigenomic by Countries
7.2 Europe Epigenomic Market Size by Type
7.3 Europe Epigenomic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Epigenomic by Countries
8.2 Middle East & Africa Epigenomic Market Size by Type
8.3 Middle East & Africa Epigenomic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Epigenomic Market Forecast
10.1 Global Epigenomic Market Size Forecast (2018-2023)
10.2 Global Epigenomic Forecast by Regions
10.2.1 Global Epigenomic Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Epigenomic Forecast by Type
10.8 Global Epigenomic Forecast by Application

11 Key Players Analysis
11.1 Roche Diagnostics
11.1.1 Company Details
11.1.2 Epigenomic Product Offered
11.1.3 Roche Diagnostics Epigenomic Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Roche Diagnostics News
11.2 Thermo Fisher Scientific
11.2.1 Company Details
11.2.2 Epigenomic Product Offered
11.2.3 Thermo Fisher Scientific Epigenomic Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Thermo Fisher Scientific News
11.3 Eisai
11.3.1 Company Details
11.3.2 Epigenomic Product Offered
11.3.3 Eisai Epigenomic Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Eisai News
11.4 Novartis
11.4.1 Company Details
11.4.2 Epigenomic Product Offered
11.4.3 Novartis Epigenomic Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Novartis News

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Epigenomic
Figure Epigenomic Report Years Considered
Figure Market Research Methodology
Figure Global Epigenomic Market Size Growth Rate 2013-2023 ($ Millions)
Table Epigenomic Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Reagents
Table Major Players of Kits
Table Major Players of Instruments
Table Major Players of Enzymes
Table Major Players of Services
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Epigenomic Market Size Market Share by Type (2013-2018)
Figure Global Epigenomic Market Size Market Share by Type (2013-2018)
Figure Global Reagents Market Size Growth Rate
Figure Global Kits Market Size Growth Rate
Figure Global Instruments Market Size Growth Rate
Figure Global Enzymes Market Size Growth Rate
Figure Global Services Market Size Growth Rate
Figure Epigenomic Consumed in Oncology
Figure Global Epigenomic Market: Oncology (2013-2018) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure Epigenomic Consumed in Non Oncology
Figure Global Epigenomic Market: Non Oncology (2013-2018) ($ Millions)
Figure Global Non Oncology YoY Growth ($ Millions)
Table Global Epigenomic Market Size by Application (2013-2018) ($ Millions)
Table Global Epigenomic Market Size Market Share by Application (2013-2018)
Figure Global Epigenomic Market Size Market Share by Application (2013-2018)
Figure Global Epigenomic Market Size in Oncology Growth Rate
Figure Global Epigenomic Market Size in Non Oncology Growth Rate
Table Global Epigenomic Revenue by Players (2016-2018) ($ Millions)
Table Global Epigenomic Revenue Market Share by Players (2016-2018)
Figure Global Epigenomic Revenue Market Share by Players in 2017
Table Global Epigenomic Key Players Head office and Products Offered
Table Epigenomic Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Epigenomic Market Size by Regions 2013-2018 ($ Millions)
Table Global Epigenomic Market Size Market Share by Regions 2013-2018
Figure Global Epigenomic Market Size Market Share by Regions 2013-2018
Figure Americas Epigenomic Market Size 2013-2018 ($ Millions)
Figure APAC Epigenomic Market Size 2013-2018 ($ Millions)
Figure Europe Epigenomic Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Epigenomic Market Size 2013-2018 ($ Millions)
Table Americas Epigenomic Market Size by Countries (2013-2018) ($ Millions)
Table Americas Epigenomic Market Size Market Share by Countries (2013-2018)
Figure Americas Epigenomic Market Size Market Share by Countries in 2017
Table Americas Epigenomic Market Size by Type (2013-2018) ($ Millions)
Table Americas Epigenomic Market Size Market Share by Type (2013-2018)
Figure Americas Epigenomic Market Size Market Share by Type in 2017
Table Americas Epigenomic Market Size by Application (2013-2018) ($ Millions)
Table Americas Epigenomic Market Size Market Share by Application (2013-2018)
Figure Americas Epigenomic Market Size Market Share by Application in 2017
Figure United States Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Canada Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Epigenomic Market Size Growth 2013-2018 ($ Millions)
Table APAC Epigenomic Market Size by Countries (2013-2018) ($ Millions)
Table APAC Epigenomic Market Size Market Share by Countries (2013-2018)
Figure APAC Epigenomic Market Size Market Share by Countries in 2017
Table APAC Epigenomic Market Size by Type (2013-2018) ($ Millions)
Table APAC Epigenomic Market Size Market Share by Type (2013-2018)
Figure APAC Epigenomic Market Size Market Share by Type in 2017
Table APAC Epigenomic Market Size by Application (2013-2018) ($ Millions)
Table APAC Epigenomic Market Size Market Share by Application (2013-2018)
Figure APAC Epigenomic Market Size Market Share by Application in 2017
Figure China Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Japan Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Korea Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure India Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Australia Epigenomic Market Size Growth 2013-2018 ($ Millions)
Table Europe Epigenomic Market Size by Countries (2013-2018) ($ Millions)
Table Europe Epigenomic Market Size Market Share by Countries (2013-2018)
Figure Europe Epigenomic Market Size Market Share by Countries in 2017
Table Europe Epigenomic Market Size by Type (2013-2018) ($ Millions)
Table Europe Epigenomic Market Size Market Share by Type (2013-2018)
Figure Europe Epigenomic Market Size Market Share by Type in 2017
Table Europe Epigenomic Market Size by Application (2013-2018) ($ Millions)
Table Europe Epigenomic Market Size Market Share by Application (2013-2018)
Figure Europe Epigenomic Market Size Market Share by Application in 2017
Figure Germany Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure France Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure UK Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Italy Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Russia Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Spain Epigenomic Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Epigenomic Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Epigenomic Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Epigenomic Market Size Market Share by Countries in 2017
Table Middle East & Africa Epigenomic Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Epigenomic Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Epigenomic Market Size Market Share by Type in 2017
Table Middle East & Africa Epigenomic Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Epigenomic Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Epigenomic Market Size Market Share by Application in 2017
Figure Egypt Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Israel Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Epigenomic Market Size Growth 2013-2018 ($ Millions)
Figure Global Epigenomic arket Size Forecast (2018-2023) ($ Millions)
Table Global Epigenomic Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Epigenomic Market Size Market Share Forecast by Regions
Figure Americas Epigenomic Market Size 2018-2023 ($ Millions)
Figure APAC Epigenomic Market Size 2018-2023 ($ Millions)
Figure Europe Epigenomic Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Epigenomic Market Size 2018-2023 ($ Millions)
Figure United States Epigenomic Market Size 2018-2023 ($ Millions)
Figure Canada Epigenomic Market Size 2018-2023 ($ Millions)
Figure Mexico Epigenomic Market Size 2018-2023 ($ Millions)
Figure Brazil Epigenomic Market Size 2018-2023 ($ Millions)
Figure China Epigenomic Market Size 2018-2023 ($ Millions)
Figure Japan Epigenomic Market Size 2018-2023 ($ Millions)
Figure Korea Epigenomic Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Epigenomic Market Size 2018-2023 ($ Millions)
Figure India Epigenomic Market Size 2018-2023 ($ Millions)
Figure Australia Epigenomic Market Size 2018-2023 ($ Millions)
Figure Germany Epigenomic Market Size 2018-2023 ($ Millions)
Figure France Epigenomic Market Size 2018-2023 ($ Millions)
Figure UK Epigenomic Market Size 2018-2023 ($ Millions)
Figure Italy Epigenomic Market Size 2018-2023 ($ Millions)
Figure Russia Epigenomic Market Size 2018-2023 ($ Millions)
Figure Spain Epigenomic Market Size 2018-2023 ($ Millions)
Figure Egypt Epigenomic Market Size 2018-2023 ($ Millions)
Figure South Africa Epigenomic Market Size 2018-2023 ($ Millions)
Figure Israel Epigenomic Market Size 2018-2023 ($ Millions)
Figure Turkey Epigenomic Market Size 2018-2023 ($ Millions)
Figure GCC Countries Epigenomic Market Size 2018-2023 ($ Millions)
Table Global Epigenomic Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Epigenomic Market Size Market Share Forecast by Type (2018-2023)
Table Global Epigenomic Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Epigenomic Market Size Market Share Forecast by Application (2018-2023)
Table Roche Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Diagnostics Epigenomic Revenue and Gross Margin (2016-2018)
Figure Roche Diagnostics Epigenomic Market Share (2016-2018)
Table Thermo Fisher Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table Thermo Fisher Scientific Epigenomic Revenue and Gross Margin (2016-2018)
Figure Thermo Fisher Scientific Epigenomic Market Share (2016-2018)
Table Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eisai Epigenomic Revenue and Gross Margin (2016-2018)
Figure Eisai Epigenomic Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Epigenomic Revenue and Gross Margin (2016-2018)
Figure Novartis Epigenomic Market Share (2016-2018)